Pharsight

Drugs that contain Metoprolol Succinate

1. Kapspargo Sprinkle patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9700530 SPIL Capsule dosage form of metoprolol succinate
Jul, 2035

(11 years from now)

US9504655 SPIL Capsule dosage form of metoprolol succinate
Jul, 2035

(11 years from now)

Market Authorisation Date: 26 January, 2018

Treatment: NA

Dosage: CAPSULE, EXTENDED RELEASE;ORAL

More Information on Dosage

KAPSPARGO SPRINKLE family patents

Family Patents